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Objective: To achieve consensus on the minimum reporting set of study variables for fetal 
growth restriction (FGR) research studies. Determination of a list of variables considered 
essential to be reported independent of a specific hypothesis is likely to improve the study 
quality by inclusion of essential end-points, enhancing the consistency among studies and 
minimizing potential confounding. This in turn can accelerate generation of generalizable 
knowledge either by standardization of individual study designs or by enhancing the possibility 
of individual patient data meta-analysis merging a number of uniformly structured datasets.  
 
Study Design: An expert panel, identified based on their publication record as lead or senior 
authors in studies of FGR, was requested to select a set of essential study parameters from a 
literature-based list utilizing the Delphi consensus methodology. We collected responses in four 
consecutive rounds by online questionnaires presented to panelists through a unique token-
secured link for each round. Variables were selected in three rounds based on the concurrence 
on Likert scale scoring. In the final round, retained parameters were categorized as essential (to 
be reported in all FGR studies) or recommended (important but not mandatory). 
 
Results: 87/100 experts agreed to participate and 62 (71%) completed all four rounds. 
Agreement was reached for 16 essential and 30 recommended parameters including maternal 
characteristics, prenatal investigations, management and pregnancy/neonatal outcomes. 
Essential parameters included hypertensive complications in the current pregnancy, smoking, 
parity, maternal age, abdominal circumference, estimated fetal weight, umbilical artery Doppler 
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(pulsatility index and end-diastolic flow), middle cerebral artery Doppler, indications for 
intervention, pregnancy outcome (live birth, stillbirth or neonatal death), gestational age at 
delivery, birthweight, birthweight centile, mode of delivery and Apgar score at 5 minutes.   
 
Conclusions: We present a list of essential and recommended parameters that characterize 
FGR independent of study hypotheses. Uniform reporting of these variables in prospective 
clinical research is expected to improve data quality, study consistency and ultimately our 
understanding of FGR. 
 





Fetal growth restriction (FGR) remains a major cause of adverse perinatal outcome, in particular 
stillbirth, neonatal death, hypoxic ischemic encephalopathy and cerebral palsy.1,2,3 FGR may 
arise as a consequence of several underlying causes. Even cases that are primarily due to 
placental dysfunction have significant variability in their phenotype. The underlying phenotype, 
the gestational age at which FGR is detected, and the management approach taken can all 
significantly impact outcome.4  
 
Lack of consistency in outcome reporting can be disruptive to progress in any speciality. With 
this in mind 78 editors of journals of Women’s Health came together to form a consortium 
supporting the development, dissemination, and implementation of core outcome sets.5 This has 
triggered the development of a number of core outcome set initiatives using the Delphi method.6 
These are agreed, clearly defined minimum sets of outcomes that should be measured in a 
standardised manner and reportedconsistently.7 Their development and implementation is 
valuable for  the design and reporting of clinical studies, and ultimately aims to improve  clinical 
care.  
 
In addition to core outcome sets, we argue that exposure variables should also be standardized 
- irrespective of the primary study hypothesis. In other words, prospective clinical studies that do 
not consider key variables associated with FGR may be at risk of confounding and bias, as they 
lack contextual information for assessing the generalizability of findings.  Development of a set 
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of core variables that should be reported in any prospective clinical research study on FGR 
enhances the consistency of study design independent of the primary hypothesis. This in turn 
would improve study quality and impact by consistently capturing essential end-points, 
decreasing risk of confounding and facilitating the possibility of conducting individual patient 
data meta-analysis and merging a number of uniformly structured datasets.  
 
We recently used the Delphi procedure to reach consensus on the definition of the phenotype of 
FGR.8 Accordingly, it was the aim of this study to reach consensus on a list of clinical variables 
that should be considered essential to report for any study of pregnancies complicated by FGR. 




















The methodology of the Delphi procedure as applied in this study has been previously 
described.8 Ethics approval was not required. We identified the panel members based on their 
publication record as lead or senior authors in studies of FGR. When inviting panel members we 
specifically sought wide geographic representation in order to facilitate generalizability of a 
minimum reporting set (MRS) of variables. We performed a search in PubMed using keyword 
‘fetal growth restriction’. Authors with more than one recent (last ten years) publication were 
approached. Moreover, we asked the panel in the invitational email to pass the invitation to all 
potential experts that they thought should to be added to the list of experts. Sample sizes for 
Delphi studies are variable. We aimed for a sample size between 30 and 100 because this 
would be small enough to include only true experts and maintain speed in the process, and 
large enough to ensure representative pooling of judgment. By inviting this pool of experts, we 
were certain that we would reach this goal, anticipating drop-out. Because we found relatively 
few experts from Asian and African countries, we actively asked the author group in the first 
Delphi to recommend experts from those continents.  




Data were collected in four consecutive rounds by online questionnaires that were presented to 
panelists through a unique token-secured link for each round. Responses were captured in 
Limesurvey version 2.50. Non-responders received reminder emails after two and four weeks 
and were excluded from subsequent survey rounds if no response was obtained. Each round 
included the option of offering additional items or suggestions as well as withdrawal of items 
from the procedure. Newly suggested items were categorized and carefully considered (i.e. 
discussed by the members of the Steering Group, who decided whether it would be appropriate 
to include them in the next round) by the panel of experts who agreed to participate for their 
applicability in this procedure. All additional suggested variables were included in the next round 
for consideration of the entire panel. 
 
First round 
A primary list of items to be considered in the MRS was presented in the following categories: 
maternal characteristics, prenatal investigations, clinical management and delivery/neonatal 
outcome. The list of variables for the first round was generated using a combination of narrative 
reviews and the expertise of the authors. Panel members were asked to rate each item on a 5-
point Likert scale (1: very unimportant; 2: unimportant; 3: neutral; 4: important; 5: very 
important). They were also asked to suggest additional parameters. 
 
Second and third rounds 
This article is protected by copyright. All rights reserved.
  
 
In the second round, accepted and newly recommended items in round one were presented to 
the panel with the answer options ‘yes’ or ‘no’. Items that in Round 1 had scored the predefined 
cut-off of a median Likert score of five were considered as inclusions and presented to the panel 
for verification for inclusion in the MRS, while items with a median score of four were presented 
to verify exclusion. Items with a median score of three or lower were considered rejected and 
verification of rejection was requested. A predefined cut-off level of 70% agreement was used to 
define consensus for these questions. This meant that 70% of respondents selected "yes" for 
inclusion of a particular variable. In the third round, parameters that fell within a 60-70% 
agreement were presented to the panel for re-consideration.  
 
Final round 
The purpose of this round was to categorize all items that were retained after three rounds as 
either ‘essential’ or ‘recommended’. ‘Essential’ parameters were those that the panel advised 
should be reported in all FGR studies, while ‘recommended’ parameters were those defined as 
important, though not mandatory for reporting. In this round, a cut-off level of 70% agreement 




In the first round a median of Likert 5 was sufficient for inclusion, these were brought back for 
confirmation in the second round. Items that scored a median of Likert 4 were thought to be 
doubtful for inclusion and presented in the second round to vote on whether or not to include 
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them, with a 70% threshold for agreement. Items that scored a Likert 3 or lower were presented 
again to confirm rejection, also with a 70% threshold for agreement. Items that scored 60-70% 
agreement for inclusion in the second round were brought back for confirmation for rejection. 
The agreement is only for those who completed that particular round. Therefore, the exact cut 
off is dependent on how many panel members completed that specific round and not those at 
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87 experts, predominantly European and North American maternal-fetal medicine specialists, 
agreed to participate in round one of the survey (Table 1). The flow chart of the study is 
displayed in Figure 1. Of all invited experts, 62 panelists (71%) completed all four rounds 
(Supplementary material). A list of the parameters presented to the panel in the first round is 
shown in Supplementary Table 2. In the first round, 54 parameters scored a Likert scale of five, 
while 31 and 6 parameters scored a Likert of four and three, respectively (Supplementary 
Figures 1-4). Thirteen additional parameters were suggested (Supplementary Table 3).  
 
In the second and third rounds, 46 items were selected for consideration as essential or 
recommended in the final round. With the exception of ‘maternal hypertensive disorders in 
pregnancy’ and ‘need for emergency cesarean section’, all items were in the original list. With 
the predefined threshold of agreement set at 70%, 16 of these were selected as essential in the 
final round (Table 2). For these variables the median agreement was 79% (range 70-100%), 
with a median deviation from perfect agreement of 21% (0-30%). Thirty parameters were 
identified as recommended (Table 3). For these, the median agreement was 53% (range 30-











Summary of the findings  
We presented an international expert panel with a range of variables that may be captured in 
clinical studies and utilized the Delphi procedure to reach consensus on parameters that are 
considered essential; and those that are non-essential but recommended. More than 70% of 
experts agreed that these variables were essential. A more inclusive set of recommended 
parameters expands significantly on maternal characteristics, diagnostic and surveillance 
parameters, as well as delivery circumstances. More than 60% of experts agreed on these 
variables. These findings suggest that recommended variables may be of greater value for 
selected research questions.  
Strengths and Limitations 
The Delphi methodology is widely used in the development of core outcome sets and when 
trying to reach a consensus. However, there are a number of limitations. Firstly, we did not have 
data on the demographic characteristics of the experts who chose not to participate and we did 
not investigate the reasons for dropping out. One probable reason is that healthcare 
professionals might be overwhelmed by the large number of surveys they receive; several were 
issued at the same time. However, a response rate of 71% (62 out of 87) is considered 
acceptable for a Delphi consensus. Notably, the distribution of participants and level of expertise 
was similar in the final round in comparison to the first round. This means that the drop-out did 
not influence the global coverage, nor the level of experience of the panel. We had the highest 
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level of drop-out during the holiday seasons. When contacting the participants by phone, most 
participants informed us that they simply forgot to complete the survey. Moreover, in the free 
text answers, we did not get any signal that the experts who dropped out were critical of the 
process or unhappy about the attempt to gain consensus. Secondly, despite our efforts to have 
an international expert representation, 76% were from Europe and North America, which may 
be explained by the volume of publications on fetal growth restriction originating from these two 
continents. Moreover, the overwhelming majority of the experts who participated were 
European. Given the differences in practice in Europe and the United States, in particular 
regarding the use of Doppler parameters, the potential implications on clinical practice, research 
studies and training of obstetricians and sonographers should be considered. 
Interpretation of findings and comparison with existing literature 
The present study provides a list of variables that should represent the minimal reporting set for 
prenatally initiated research studies of FGR.9-17 Regarding the items related to the prenatal 
investigations that were considered essential to report, the role of fetal and uterine artery 
Doppler has recently gained attention, both as markers of failure to reach growth potential and 
as prognostic markers for both short- and long-term perinatal outcomes.18-22 In a recent meta-
analysis abnormal cerebroplacental ratio (CPR) in small fetuses was associated with an 
increased risk of cesarean section for fetal distress (OR 7.4), low 5-min Apgar score (OR 6.9), 
neonatal unit admission (OR 13.0) and neonatal complications (OR 20.4).22 One potential 
explanation of the fact that the expert panel did not vote for the uterine artery Doppler to be 
essential, as its main role is in the identification of the pregnancies at risk of fetal growth 
restriction secondary to placental insufficiency, rather than influencing the management or the 
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timing of delivery of these pregnancies. Another interesting observation is that the ductus 
venosus Doppler was not prioritized by the expert panel. The most likely explanation is that the 
significance of the ductus venosus Doppler is only relevant to early-onset FGR. Another 
explanation is that the practice of monitoring these complicated pregnancies differs, with some 
fetal medicine experts rely on fetal Doppler, while others use CTG (or comuterized CTG), and 
others favour the use of biophysical profile. 
Clinical and Research Implications 
Heterogeneity of study design and outcome reporting is frequent in FGR research, limiting their 
generalizability.23-26 We present a set of variables to be utilized by researchers in their study 
design. The range of variables to be selected from the recommended list will depend on the 
desired precision of ascertainment. The inclusion of the essential variables is likely to improve 
the study data quality of future studies in this field and allow robust assessment for 
heterogeneity when assessed in the context of meta-analyses. Having standardized parameters 
also allows more in-depth meta-analysis by allowing meta-regression procedures on potential 
covariates with relevant effects on management or diagnostic performance. Any variables 
required as part of a specific study question must of course be included in addition to these 
essential and recommended variables. 
By using expert opinions in a semi-anonymous (the panel members were aware of the list of 
participants, as it was provided to ask for additional experts but the individual answers were 
anonymous) Delphi method each vote carries equal weight so can provide specific information 
while suppressing dominant individual opinions. In the Delphi method, repeated rounds of voting 
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on items by the expert panel are organized and structurally fed back in increasing detail until a 
consensus is achieved. The Delphi process encourages experts to reconsider their opinion in 
response to the group answers in every subsequent round. Delphi procedures are widely used 
to reach consensus definitions or core outcome sets.27,28 
In this study we have purposely focused on exposures and immediate/short-term outcomes. A 
forthcoming and complementary Delphi procedure is being performed to reach consensus 
among a larger group of stakeholders (including neonatologists, midwives, general 
obstetricians, fetal medicine experts and patient representatives) around a broader set of 
outcome parameters, such as neonatal morbidity and child health and development, that need 
to be reported in a core outcome set (COS). The outcome parameters discussed and voted 
upon in the MRS procedure are summarized here and have been used to inform the first round 
of the complementary COS procedure, alongside the literature review performed for the COS.  
A strategy for the standardization of preeclampsia research study design was published 3 years 
ago,29 but a similar strategy focusing on FGR is yet to be established. Adherence to 
standardized protocols is likely to hasten our understanding of the etiology of FGR and 
development of effective treatment strategies. This set of variables, when combined with the 
Standard Protocol Items: Recommendations for Interventional Trials (SPIRIT) statement,30,31 
should enable the researchers to design high quality FGR research studies. The team of 
involved key stakeholders has the potential to set up an international network, which could be a 
potent vehicle for the development of international guidelines, registries and setting research 
priorities for FGR. 




This study provides a list of variables that are useful to describe key features of FGR. The 
uniform ascertainment of these variables, independent of the specific hypothesis to be tested, 
can potentially significantly decrease heterogeneity of prospective research. Accordingly, we 
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Table 1. Characteristics of the expert panel members who completed Round 1 (n=87). 
 
Characteristics of participants % 
Continent of practice 
 Europe 56 
North America 20 




Level of experience / academic rank 
 Professor 48 
Associate Professor / Assistant Professor 24 
Consultant/ Specialist 22 
Registrar/Trainee 1 
Non-clinical investigator/researcher 3 
Speciality 
 General gynaecologist 2 
Maternal-Fetal Medicine Specialist 87 
Subspecialty Fellow 3 
Neonatologist 1 
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Pathologist / Fetal Physiologist / Radiologist / Epidemiologist 6 
Years of practice in current function 




Level of care 
 Non-fetal maternal center 5 
Fetal medicine center offering prenatal diagnosis but no fetal    therapy 26 
Fetal medicine center offering prenatal diagnosis and fetal therapy 63 
Private hospital/tertiary care facility 6 
Referral centre for pregnancies complicated by fetal growth restriction 92 
Deliveries 
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Table 2. Parameters identified as essential by consensus. 
Minimum reporting set (MRS) essential parameters % consensus 
Maternal characteristics 
 • Hypertensive complications in current pregnancy 92 
• Smoking 79 
• Parity 79 
• Maternal age 77 
Items for investigations/assessment 
 • Abdominal circumference 89 
• Estimated fetal weight 89 
• Umbilical artery Doppler index 82 
• Umbilical artery end-diastolic flow 74 
• Middle cerebral artery Doppler 70 
Items for management 
 • Indications for intervention 72 
Pregnancy outcome 
 • Gestational age at delivery 100 
• Birthweight 98 
• Pregnancy outcome (livebirth, stillbirth, intrapartum or neonatal death) 97 
• Mode of delivery 79 
• Apgar score at 5 minutes 74 
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• Birthweight centile 72 




Table 3. Parameters identified as recommended by consensus. 
Parameters recommended to report % consensus 
Maternal characteristics 
 • Maternal body mass index 69 
• Prior fetal growth restriction or small baby 61 
• Maternal ethnic background 52 
• Drug/alcohol abuse 51 
• Prior essential hypertension 49 
• Prior preeclampsia 46 
• Prior autoimmune disease 39 
• Prior stillbirth 39 
• Pre-existing diabetes 37 
• Pre-existing vascular disease 36 
• Pre-existing renal impairment 36 
• Mode of conception  34 
Items for investigations/ assessment 
 • Growth centile formula 64 
• Femur length 61 
• Head circumference 57 
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• Amniotic fluid index / single deepest pocket 54 
• Uterine artery Doppler index 41 
• Fetal karyotype 33 
Items for management 
 • Interval between last examination and delivery 69 
• Method of monitoring 64 
• Administration of steroids to promote fetal lung maturity 64 
• Intervals between assessments in longitudinal studies 57 
• Administration of low dose aspirin 54 
• Frequency of monitoring 44 
• Administration of MgSO4 30 
Pregnancy outcome 
 • Need for emergency cesarean section 66 
• Fetal sex 62 
• Umbilical artery pH  59 
• Signs of fetal distress/hypoxia on fetal heart rate monitoring 56 
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Figure 1. The Delphi flow chart 
Supplementary Figure 1. Likert scores of the parameters describing maternal characteristics 
Supplementary Figure 2. Likert scores of parameters describing investigations/assessment 
Supplementary Figure 3. Likert scores of parameters describing management 
Supplementary Figure 4. Likert scores of parameters describing pregnancy outcome (S4a) 
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